Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy in porphyria.

B Samuels, W R Bezwoda, D P Derman

    South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
    |June 9, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Analyzing the effect of physician assignment in the survival of patients with advanced non-small-cell lung cancer.

    Current oncology (Toronto, Ont.)·2020
    Same author

    A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies.

    Investigational new drugs·2020
    Same author

    Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens.

    Investigational new drugs·2018
    Same author

    CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Plasma Lactoferrin Concentration in Acute Non-Lymphocytic Leukaemia (ANLL).

    Leukemia & lymphoma·2016
    Same author

    Acute Lymphoblastic Leukaemia in Adults. Prognostic Factors and 10 Year Treatment Results.

    Leukemia & lymphoma·2016
    Same journal

    SAMA Health Summit Abstracts.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    On behalf of the South African Medical Association (SAMA), The Scientific Committee of the SAMA Health Summit, is pleased to pesent this abstract issue, showcasing the posters and oral presentations delivered at the Summit, which was held from 22-24 May 2026.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Proceedings of the 2<sup>nd</sup> Data Driven Surgery Conference (DDSC 2025).

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Clinical practice guidelines for the management of fever and neutropenia in South African children and adolescents with cancer.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    The changing fortunes of the District Health System in SA (1994 - 2020): A retrospective review.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Thomas Micheal Guntram Ignaz Rehle (1951 - 2025).

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    See all related articles

    Chemotherapy can be safely administered to patients with hepatic porphyrias, including porphyria variegata. Treatment decisions for these patients should prioritize managing their underlying cancer.

    Area of Science:

    • Hepatology
    • Oncology
    • Genetics

    Background:

    • Hepatic porphyrias are rare genetic disorders affecting heme biosynthesis.
    • Patients with hepatic porphyrias may develop disseminated malignant diseases requiring chemotherapy.
    • The safety of chemotherapy in this patient population is a significant clinical concern.

    Observation:

    • This study reviewed the clinical courses of 5 patients with hepatic porphyrias (4 with porphyria variegata) undergoing chemotherapy.
    • Antineoplastic agents were administered to these patients.
    • No porphyric crises were precipitated by the chemotherapeutic agents used.

    Findings:

    • Chemotherapy can be safely used in patients with hepatic porphyrias.
    • The use of antineoplastic drugs did not trigger porphyric crises in the observed cases.

    Related Experiment Videos

  • The primary treatment focus should remain on the management of the malignant disease.

    • Implications:

    • Oncologists can consider chemotherapy for patients with hepatic porphyrias without undue fear of precipitating porphyric crises.
    • This finding supports evidence-based treatment protocols for cancer in patients with rare genetic disorders.
    • Further research may explore specific chemotherapy regimens and their long-term effects in this population.